The dopamine receptor D1 gene and ADHD: A piece of the genetic puzzle?

Attention-deficit/hyperactivity disorder (ADHD) is recognized as the most prevalent mental health disorder of childhood, affecting about 3 to 5 percent of school-age children worldwide. The hallmarks of the disorder are age-inappropriate levels of inattention, hyperactivity and impulsiveness. These problems often lead to underachievement in school and can have a negative impact on interpersonal relationships and on self-esteem. ADHD symptoms often persist into adolescence and adulthood, resulting in lifelong difficulties in academic, occupational, social and family functioning. In addition, there is evidence that ADHD may be a risk factor for other serious mental health problems and specific learning disabilities. All told, ADHD is a major public health issue.

Twin, family and adoption studies have produced strong evidence that ADHD is, in large part, genetically determined. Inheritance of the disorder is complex. Multiple genes, each of small to moderate effect, are likely to be involved. Although the neurobiological basis of ADHD remains to be fully understood, there is much evidence pointing to dysregulation of the dopamine neurotransmitter system as an underlying factor. Because of this, genes of the dopamine system are considered as candidates for involvement in the disorder. Genes that have been investigated are the ones encoding the five receptors in the brain, D1D5, through which dopamine acts. Such studies, to date, have found strong evidence for the involvement of two of these receptor genes, those encoding the D4 and D5 receptors, but little or no evidence for the involvement of either D2 or D3. Recently, the authors obtained evidence for involvement of the remaining member of this class of genes, the gene encoding dopamine receptor D1 (DRD1).

Combined evidence from a number of human and animal studies suggested DRD1 to be a particularly strong candidate for involvement in susceptibility to ADHD. To test this, the authors i

Contact: Aimee Midei
Molecular Psychiatry

Page: 1 2

Related biology news :

1. Vollum scientists find new form of dopamine transmission
2. How amphetamine affects the dopamine transporter
3. Drug-naive schizophrenia: The dopamine connection
4. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
5. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
6. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
7. Two-pronged attack targeting EGF receptor hinders cancer cell growth
8. Tamoxifen stimulates breast cancer growth following alteration of estrogen receptor
9. Dioxin-receptor network identified
10. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic
11. Scientists at Scripps Research Institute describe structure of receptor on surface of 1918 flu virus

Post Your Comments:

(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered ... common and aggressive adult brain cancer—announced today the appointments of its first Senior ... with supporting the organization’s initiatives and overall vision. , "Senior Fellows are more ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... development services, today announced that the company has received ISO9001:2015 certification for ... diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... In its ... feature interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of ... the company announced on June 16 that starting July 5 it would ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 23, 2020 , ... ... today announced that it has filed an Investigational New Drug application (IND) with ... trial of its lead drug candidate NBTX-001 in patients with panic disorder (PD). ...
(Date:6/11/2020)... ... June 09, 2020 , ... TRX Systems, developer ... Micro-Tracer Solution, a highly accurate, contact tracing solution for identification of employees ... tracing, a core disease control measure, is a key strategy for preventing further ...
(Date:5/30/2020)... (PRWEB) , ... May 29, 2020 , ... ... biotech, medical device, diagnostics, and animal health markets, has enabled Cytovale, Inc., a ... cell mechanics and machine learning, to achieve their first patient in (FPI) in ...
(Date:5/26/2020)... ... 2020 , ... Brilliant , the leading smart home control and lighting ... announce a new integration to bring more convenience, simplicity, and security to the smart ... Connect® can now be controlled from Brilliant’s in-wall touchscreen control panels and mobile app. ...
Breaking Biology Technology:
Cached News: